| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a32b9974789b1f514beab8580dc3808
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3ac589f041061087592b58ef62dab44e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2603-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C311-29
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C217-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-34 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C311-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-11 |
| filingDate |
2008-09-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62154a2eda04405fc427d9b4b03f2bb8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27ceaa5873924fdce9d141695600904a |
| publicationDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009076152-A1 |
| titleOfInvention |
Novel Compounds Active as Muscarinic Receptor Antagonists |
| abstract |
The invention relates to compounds of formula n n n n n n n n n n processes and intermediates for their preparation, their use as muscarinic antagonists and pharmaceutical compositions containing them. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105044263-A |
| priorityDate |
2007-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |